Noveris Health Sciences is trading at CA$0.37 (-10.84%), with no clear catalyst confirmed.
- No August 11, 2026 company-specific announcement was identified.
- Management previously stated on August 6, 2026 it was unaware of any material operational change explaining increased market activity.
- The move follows extreme volatility, including a 20.29% gain on August 10 and sharp earlier declines; broader markets were only modestly lower.